Menssana Research laboratories have established a new role for breath testing in the early detection of disease. Scientists there have developed a portable breath collection apparatus that can collect breath samples for highly sensitive laboratory analysis virtually anywhere.
Read More
Headquartered in Halifax, Nova Scotia, Canada, MedMira is developing a robust pipeline of tests based on its patented Rapid Vertical Flow technology. The technology facilitates the formation of highly specific antigen-antibody reactions, allowing specific biomarkers in many sample types—including human whole blood, serum, or plasma—to be captured and visualized on a unique membrane.
Read More
Technologies rarely advance at a steady and predictable pace, but new platforms and newer ideas are already shaping the future of clinical lab testing. This article from the April 2014 issue highlights a handful of companies that are working to bring new diagnostic technologies to market and improve patient care.
Read More
CDC’s grant of more than $1.25 million to the College of American Pathologists will help laboratory professionals improve the delivery of patient testing guidelines and cancer reporting.
Read MoreA new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read More